Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GH Guardant Health Inc.

盘后交易 09-25 17:08:02 EDT

177.25

+0.80

+0.45%

盘后176.80

-0.45-0.25%

16:56 EDT

最高179.97	最低174.50	成交量157.84万
今开178.50	昨收176.45	日振幅3.10%
总市值237.86亿	流通市值230.03亿	总股本1.34亿
成交额2.80亿	换手率1.22%	流通股本1.30亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":177.25,"timestamp":1790366400000,"preClose":176.45,"halted":0,"volume":1578388,"hourTrading":{"tag":"盘后","latestPrice":176.8,"preClose":177.25,"latestTime":"16:56 EDT","volume":25400,"amount":4502105.042,"timestamp":1790369768175,"change":-0.45,"changeRate":-0.002539,"amplitude":0.002539},"delay":0,"changeRate":0.00453386228393319,"floatShares":129778058,"shares":134196170,"eps":-3.503749,"marketStatus":"盘后交易","change":0.8,"latestTime":"09-25 17:08:02 EDT","open":178.5,"high":179.9699,"low":174.5,"amount":280425377.32384,"amplitude":0.031,"askPrice":177.25,"askSize":100,"bidPrice":174.34,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-3.503749,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1790380800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":176.45,"preHourTrading":{"tag":"盘前","latestPrice":178.48,"preClose":176.45,"latestTime":"09:28 EDT","volume":825,"amount":146869.92375,"timestamp":1790342880117,"change":2.03,"changeRate":0.011505,"amplitude":0.017449},"postHourTrading":{"tag":"盘后","latestPrice":176.8,"preClose":177.25,"latestTime":"16:56 EDT","volume":25400,"amount":4502105.042,"timestamp":1790369768175,"change":-0.45,"changeRate":-0.002539,"amplitude":0.002539},"volumeRatio":0.661226,"impliedVol":0.5539,"impliedVolPercentile":0.2032},"requestUrl":"/m/hq/s/GH","defaultTab":"news","newsList":[{"id":"1194793262","title":"异动解读｜Guardant Health盘中上涨5.31%，Shield血液检测再获重磅保险覆盖协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1194793262","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194793262?lang=zh_cn&edition=full","pubTime":"2026-09-16 00:37","pubTimestamp":1789490240,"startTime":"0","endTime":"0","summary":"9月15日，Guardant Health盘中上涨5.31%，报176.75美元/股，成交额1.89亿美元。消息面上，公司宣布Evernorth旗下Evicore已将其Shield血液检测纳入结直肠癌筛查承保范围，覆盖自明年1月1日起正式生效。此前公司已与Carelon达成类似协议，商业保险覆盖人群已扩展至约9000万人，占美国符合条件患者的75%。此次新增Evicore覆盖，进一步打开Shield的商业化空间。Guardant Health是一家精密肿瘤学公司，利用血液检测、真实世界数据及人工智能分析，为癌症筛查、复发监测及治疗方案选择提供关键见解。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Guardant Health大涨，Shield检测获重磅保险覆盖","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103100254","title":"Guardant Health与Evernorth旗下Evicore达成协议，Shield血液检测自2027年1月1日起纳入结直肠癌筛查覆盖范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1103100254","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103100254?lang=zh_cn&edition=full","pubTime":"2026-09-15 04:08","pubTimestamp":1789416490,"startTime":"0","endTime":"0","summary":"Guardant Health公司宣布，Evernorth旗下的Evicore已决定将其Shield血液检测纳入结直肠癌（CRC）筛查的承保范围。这项覆盖计划将于2027年1月1日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LFSC","EKG","FFOX","GNOM","LU0320765992.SGD","BK4535","BK4585","GDOC","BK4588","BK4196","GNMX","LU0889565916.HKD","PTH","LU0109394709.USD","HELX","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116354483","title":"Guardant Health重磅里程碑：Guardant360® Cdx获FDA批准，成为阿斯利康Ectamah™（Camizestrant）晚期乳腺癌伴随诊断","url":"https://stock-news.laohu8.com/highlight/detail?id=1116354483","media":"美股速递","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116354483?lang=zh_cn&edition=full","pubTime":"2026-09-05 06:11","pubTimestamp":1788559873,"startTime":"0","endTime":"0","summary":"Guardant Health今日宣布，其Guardant360 Cdx液体活检产品已获得美国食品药品监督管理局的里程碑式批准，正式成为阿斯利康新型内分泌疗法Ectamah在晚期乳腺癌治疗中的伴随诊断工具。Guardant Health管理层在声明中表示，这一里程碑不仅是对公司技术实力的权威认可，更是对癌症患者个体化治疗承诺的有力践行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","GNOM","LU0889565916.HKD","LFSC","BK4585","BK4588","GDOC","PTH","GNMX","LU0320765992.SGD","GH","LU0109394709.USD","BK4551","EKG","BK4196","HELX","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160211496","title":"Twinstrand：法院判决公司及Uw获赔逾2.452亿美元，涵盖截至2026年5月31日的侵权损害赔偿、应计特许权使用费及利息","url":"https://stock-news.laohu8.com/highlight/detail?id=1160211496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160211496?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:01","pubTimestamp":1787569302,"startTime":"0","endTime":"0","summary":"Twinstrand公告，法院已作出裁决，判令公司及Uw获得超过2.452亿美元的赔偿金。这笔款项涵盖了截至2026年5月31日期间所发生的侵权损害、累积的特许权使用费以及相应利息。\n裁决金额之巨，彰显了司法体系对知识产权保护的坚定立场。赔偿总额精确计算至该截止日期，包括了多层次的补偿要素。侵权行为的认定范围，则明确划定在2026年5月31日之前发生的全部相关行为。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4588","BK4535","GDOC","FFOX","LU0889565916.HKD","PTH","GNMX","HELX","LU0109394709.USD","LU0320765992.SGD","BK4196","BK4585","BK4551","GNOM","EKG","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194764905","title":"Twinstrand胜诉：法院维持2023年故意侵权判决，并裁定Guardant Health 11项产品与服务须支付6%特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1194764905","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194764905?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:01","pubTimestamp":1787569276,"startTime":"0","endTime":"0","summary":"法院裁定，维持2023年关于故意侵权的判决，同时要求Guardant Health公司就其11项产品及服务所产生的销售额，向Twinstrand支付6%的特许权使用费。这一裁决意味着，Twinstrand在知识产权纠纷中取得了关键性胜利。对于Guardant Health而言，这项决定无疑构成了财务上的重大负担。Twinstrand方面则对这一结果表示认可。此次6%特许权使用费的设定，亦反映了法院对此类行为的态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4551","FFOX","GDOC","BK4585","EKG","LFSC","BK4196","GH","HELX","LU0320765992.SGD","BK4588","GNMX","LU0889565916.HKD","PTH","GNOM","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127912643","title":"Twinstrand案判决：Guardant Health须按季度向公司及承销商汇报11款产品与服务的全美销售明细","url":"https://stock-news.laohu8.com/highlight/detail?id=1127912643","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127912643?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"根据Twinstrand方面的消息，法院判决要求Guardant Health必须履行一项新的义务——按季度提交其在美国市场上全部11款产品与服务的销售账目，以供公司与承销商查阅。\n这一判决意味着，Guardant Health在运营透明度和合规性上将面临更为严格的监督。具体而言，公司需定期整理并呈报相关销售数据，确保各方能够及时掌握其业务动态。\n此举无疑为市场参与者提供了更清晰的视角，去审视这家精准医疗领域领军企业的真实业绩表现。季度汇报机制的建立，或将进一步影响投资者对该公司未来走势的评估与判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4585","LU0889565916.HKD","GNOM","BK4551","HELX","GNMX","LFSC","GDOC","BK4196","BK4535","EKG","BK4588","FFOX","LU0320765992.SGD","PTH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136746995","title":"Twinstrand：特拉华州法院于8月21日裁定公司及华盛顿大学在针对Guardant Health的专利侵权诉讼中胜诉","url":"https://stock-news.laohu8.com/highlight/detail?id=1136746995","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136746995?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"Twinstrand宣布，特拉华州法院已于8月21日作出判决，支持公司及华盛顿大学的立场，认定其在针对Guardant Health提起的专利侵权诉讼中占据优势。这一裁决标志着这场备受关注的法律纠纷取得了阶段性胜利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","PTH","BK4551","BK4535","BK4585","GNOM","HELX","LU0320765992.SGD","FFOX","GDOC","BK4588","LU0109394709.USD","EKG","GNMX","BK4196","GH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151455938","title":"异动解读｜Guardant Health盘中上涨5.03%，报171.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151455938","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151455938?lang=zh_cn&edition=full","pubTime":"2026-08-21 02:17","pubTimestamp":1787249823,"startTime":"0","endTime":"0","summary":"8月21日，Guardant Health盘中上涨5.03%，报171.55美元/股，成交额2.07亿美元。Guardant Health所在的保健护理服务行业中，个股表现分化，其中Hims & Hers Health Inc.涨2.9%，西维斯健康涨0.52%，奎斯特诊疗涨0.23%，徕博科涨0.89%，信诺保险跌0.73%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122159182","title":"异动解读｜Guardant Health盘中上涨5.39%，Q2营收大超预期叠加全年指引上调延续强势","url":"https://stock-news.laohu8.com/highlight/detail?id=1122159182","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122159182?lang=zh_cn&edition=full","pubTime":"2026-08-07 21:56","pubTimestamp":1786111001,"startTime":"0","endTime":"0","summary":"8月7日，Guardant Health盘中上涨5.39%，报166.35美元/股，成交额4265.67万美元，延续财报发布后的上行势头。消息面上，公司此前公布的Q2财报显示营收3.35亿美元，同比增长44.3%，大幅超出市场预期的3.14亿美元；同时将全年营收指引从13.0亿-13.2亿美元上调至13.4亿-13.6亿美元，显著高于分析师预期的13.1亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Guardant Health盘中上涨5.39%，Q2营收大超预期叠加全年指引上调延续强势","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183698521","title":"异动解读｜Guardant Health夜盘上涨5.67%，Q2营收大超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1183698521","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183698521?lang=zh_cn&edition=full","pubTime":"2026-07-31 11:38","pubTimestamp":1785469114,"startTime":"0","endTime":"0","summary":"7月31日，Guardant Health夜盘上涨5.67%，报160.99美元/股。消息面上，公司盘后发布第二季度财报，营收达3.35亿美元，同比增长44.3%，显著超出市场预期的3.14亿美元；调整后每股亏损0.42美元，同比收窄。此外，近期公司获得多项积极进展，包括Guardant360 Liquid CDx获FDA批准为多癌种伴随诊断、Shield血检被纳入美国癌症学会结直肠癌筛查指南，以及多家机构上调目标价，共同提振市场情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Guardant Health夜盘上涨5.67%，Q2营收大超预期且上调全年指引","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171842386","title":"异动解读 | 夜盘大涨5.67%，Guardant Health Q2财报超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1171842386","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171842386?lang=zh_cn&edition=full","pubTime":"2026-07-31 11:28","pubTimestamp":1785468536,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.今日夜盘股价大涨5.67%，引起了市场的广泛关注。消息面上，公司于盘后发布了第二季度财报，营收达3.35亿美元，同比增长44.3%，显著超出市场预期的3.14亿美元；调整后每股亏损0.42美元，同比大幅收窄。强劲的业绩表现和乐观的指引是推动夜盘股价大涨的核心原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180776923","title":"异动解读｜Guardant Health盘后上涨6.33%，Q2营收大超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1180776923","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180776923?lang=zh_cn&edition=full","pubTime":"2026-07-31 05:56","pubTimestamp":1785448597,"startTime":"0","endTime":"0","summary":"7月31日，Guardant Health盘后上涨6.33%，报163.3美元/股，成交额3296.06万美元。消息面上，公司发布Q2财报，营收3.35亿美元，同比增长44.3%，超出市场预期的3.14亿美元；调整后每股亏损0.42美元，同比收窄。营收大幅超预期叠加指引上调，推动盘后股价走强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169449015","title":"异动解读 | Guardant Health盘后大涨7.65%，Q2财报超预期叠加多重利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1169449015","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169449015?lang=zh_cn&edition=full","pubTime":"2026-07-31 04:48","pubTimestamp":1785444536,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.今日盘后股价大涨7.65%，引发市场高度关注。作为肿瘤精准诊断龙头企业，Guardant Health的伴随诊断产品直接受益于抗癌药物使用量的增长。近期，Guardant Health还获得了一系列积极进展，包括Guardant360 Liquid CDx获得FDA批准、Shield血检被纳入美国癌症学会指南，以及多家机构上调目标价等，这些因素共同提振了市场情绪，为股价盘后大涨提供了有力支撑。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125499334","title":"异动解读｜Guardant Health盘中上涨5.02%，百时美施贵宝抗癌药业绩超预期提振肿瘤诊断板块","url":"https://stock-news.laohu8.com/highlight/detail?id=1125499334","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125499334?lang=zh_cn&edition=full","pubTime":"2026-07-31 00:15","pubTimestamp":1785428142,"startTime":"0","endTime":"0","summary":"7月30日，Guardant Health盘中上涨5.02%，报151.295美元/股，成交额1.75亿美元。消息面上，百时美施贵宝同日公布Q2财报，旗下癌症药物需求全面超预期，季度营收129.7亿美元超市场预期逾10亿美元，并大幅上调全年指引。作为肿瘤精准诊断龙头，Guardant Health的伴随诊断产品直接受益于抗癌药物使用增长。此外，公司将于当日盘后发布Q2财报，市场预期营收3.14亿美元，叠加近期Guardant360 Liquid CDx获FDA批准、Shield血检纳入美国癌症学会指南及多家机构上调目标价等利好，市场情绪偏乐观。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148213813","title":"财报前瞻 ｜Guardant Health Inc.本季度营收预计增长48.77%，机构看多占优","url":"https://stock-news.laohu8.com/highlight/detail?id=1148213813","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148213813?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:38","pubTimestamp":1784777894,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.将于2026年07月30日美股盘后发布财报，市场关注收入延续高增与亏损收窄的节奏。一致预期显示，本季度公司收入预计为3.14亿美元，同比增长48.77%；调整后每股收益预计为-0.41美元，同比改善47.05%；由于未检索到覆盖本季度的公司层面毛利率与净利润或净利率的明确口径，上述两项预测不予展示。上季度财报未给出针对本季度的明确分项指引，市场以机构一致预期为主要参考。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Guardant Health Inc.本季度营收预计增长48.77%，机构看多占优","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174386951","title":"异动解读｜Guardant Health盘中下跌5.06%，报147.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174386951","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174386951?lang=zh_cn&edition=full","pubTime":"2026-07-20 23:03","pubTimestamp":1784559813,"startTime":"0","endTime":"0","summary":"7月17日，Guardant Health盘中下跌5.06%，报147.99美元/股，成交额7437.5万美元。Guardant Health所在的保健护理服务行业中，个股中，BrightSpring Health Services涨1.89%，信诺保险涨1.01%，Hims & Hers Health涨0.52%，西维斯健康跌0.01%，BillionToOne跌4.8%。Guardant Health是一家领先的精密肿瘤学公司，利用先进的血液和组织检测、真实世界数据和人工智能分析，提供关于疾病驱动因素的关键见解，其检测覆盖早期癌症筛查、复发监测及晚期治疗方案选择等多个阶段。公司下次财报预计于7月30日盘后发布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126421777","title":"异动解读｜Guardant Health盘中下跌5.02%，报154.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126421777","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126421777?lang=zh_cn&edition=full","pubTime":"2026-07-17 03:59","pubTimestamp":1784231981,"startTime":"0","endTime":"0","summary":"7月17日，Guardant Health盘中下跌5.02%，报154.81美元/股，成交额3.46亿美元。Guardant Health所在的保健护理服务行业中，个股中，奎斯特诊疗涨3.72%，西维斯健康涨0.53%，BrightSpring Health Services跌0.04%，信诺保险跌4.86%，Hims & Hers Health跌9.46%。Guardant Health是一家领先的精密肿瘤学公司，利用先进的血液和组织检测、真实世界数据和人工智能分析，提供关于疾病驱动因素的关键见解，其检测覆盖早期癌症筛查、复发监测及晚期治疗方案选择等多个阶段。公司下次财报预计于7月30日盘后发布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129946907","title":"异动解读｜Guardant Health盘中上涨5.21%，美银大幅上调目标价至190美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129946907","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129946907?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:14","pubTimestamp":1783606452,"startTime":"0","endTime":"0","summary":"7月9日，Guardant Health盘中上涨5.21%，报168.5美元/股，成交额1.28亿美元。消息面上，美银证券近日将Guardant Health目标价从135美元大幅上调至190美元，维持买入评级。近期公司连续获得多项FDA批准，包括Guardant360 Liquid CDx获批用于非小细胞肺癌及结直肠癌伴随诊断，Shield血液检测纳入美国癌症协会结直肠癌筛查指南，叠加一季度营收3.02亿美元超预期、全年收入指引上调至13.0亿至13.2亿美元，多重利好持续推动市场情绪。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125693974","title":"异动解读｜Guardant Health盘中上涨7.47%，伯恩斯坦看好ADLT定价资格带来营收上行空间","url":"https://stock-news.laohu8.com/highlight/detail?id=1125693974","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125693974?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:01","pubTimestamp":1782914487,"startTime":"0","endTime":"0","summary":"7月1日，Guardant Health盘中上涨7.47%，报161.78美元/股，成交额1.96亿美元。消息面上，伯恩斯坦发布最新研报，给予公司\"跑赢大市\"评级及175美元目标价，指出G360 ADLT定价资格将带来可观营收上行空间，且尚未充分反映在市场一致预期中。叠加近期Guardant360 Liquid CDx获FDA批准及Shield血液检测纳入美国癌症协会筛查指南等多重催化，市场情绪持续升温。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169680987","title":"异动解读｜Guardant Health盘前上涨5.35%，伯恩斯坦看好ADLT定价资格带来营收上行空间","url":"https://stock-news.laohu8.com/highlight/detail?id=1169680987","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169680987?lang=zh_cn&edition=full","pubTime":"2026-07-01 21:23","pubTimestamp":1782912206,"startTime":"0","endTime":"0","summary":"7月1日，Guardant Health盘前上涨5.35%，报158.05美元/股，成交额67.2万美元。消息面上，伯恩斯坦在最新研报中给予该公司\"跑赢大市\"评级及175美元目标价，指出G360 ADLT定价资格将带来可观营收上行空间，且尚未充分反映在市场一致预期中。伯恩斯坦对公司2027年盈利预测较一致预期高6.6%，2028年高12.2%，并认为市场明显低估其毛利率改善潜力，向NovaSeq X平台切换预计为全年带来350至550个基点的正面影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":-0.0363},{"period":"1month","weight":0.0699},{"period":"3month","weight":0.1825},{"period":"6month","weight":1.0855},{"period":"1year","weight":2.0596},{"period":"ytd","weight":0.7275}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.2099},{"period":"1year","weight":0.1605},{"period":"ytd","weight":0.125}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Guardant Health, Inc.于2011年12月在特拉华州注册成立。该公司是一家领先的精密肿瘤学公司，致力于通过使用其专有血液测试，大量数据集和高级分析来帮助全球征服癌症。他们利用先进的血液和组织检测、真实世界数据和人工智能分析，提供关于疾病驱动因素的关键见解，从而变革患者护理。他们的检测有助于改善各个阶段的治疗效果，包括早期癌症筛查、早期癌症复发监测以及晚期癌症患者的治疗方案选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.071093},{"month":2,"riseRate":0.25,"avgChangeRate":0.034152},{"month":3,"riseRate":0.5,"avgChangeRate":-0.022808},{"month":4,"riseRate":0.375,"avgChangeRate":-0.022604},{"month":5,"riseRate":0.625,"avgChangeRate":0.118443},{"month":6,"riseRate":0.75,"avgChangeRate":0.091261},{"month":7,"riseRate":0.75,"avgChangeRate":0.055},{"month":8,"riseRate":0.5,"avgChangeRate":0.070736},{"month":9,"riseRate":0.375,"avgChangeRate":-0.043896},{"month":10,"riseRate":0.285714,"avgChangeRate":0.030366},{"month":11,"riseRate":0.75,"avgChangeRate":0.130427},{"month":12,"riseRate":0.5,"avgChangeRate":-0.066498}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}